i regret not buying more in the cr

I must confess I have picked up a few more on market.

I kept changing my mind late last year but the more I think about this one the more I want and they are hard to get a lower levels.

I can't argue the science like you guys or connect the dots like Twin over on the ADO thread but I am really impressed with the whole CR and the business focus and management restructure.

As usual I am starting to believe that I have jagged massive potential at a steal price.

The hocking family have effective control now and it looks like they wanted that but the way the CR was underwritten. No one else could have more than 5% -

http://www.phylogica.com/media/Phylogica-19June-brokers-web-version.pdf

or they would have disclosed by now although there has not been an official 3B so I am not sure how they would exactly calculate their holding.

Anyone know who Andrew Swift or Ascent Biomedical are?

By my estimation the top 20 must hold around 55-60% of the shares - I don't know many companies with that level of concentration and if they all stay true it means the upside is going to be thin and fast . . .

If in fact there is any reason for upside . . . .

I am starting to wonder if a significant Janssen announcement doesn't see the SP go nuts if people notice - like 10-20c area or a MCAP of 100-200m . . .